Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
Oncolytic Virotherapy · 2018
DOI: 10.2147/ov.s179335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncolytic Virotherapy, 2018. Verfasst von Chase Burton und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Medical University of South Carolina, SC, USA, bartee@musc.edu. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Medical University of South Carolina, SC, USA, bartee@musc.edu.
- Department of Neurosurgery, Medical University of South Carolina, SC, USA.
- Department of Radiation Oncology, Medical University of South Carolina, SC, USA.
Förderung
- NIAID NIH HHS
- NCI NIH HHS
Zitieren
APA
Burton, C., Das, A., McDonald, D., Vandergrift, W. A., Patel, S. J., Cachia, D., & Bartee, E. (2018). Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme. Oncolytic Virotherapy. https://doi.org/10.2147/ov.s179335
Vancouver
Burton C, Das A, McDonald D, Vandergrift WA, Patel SJ, Cachia D, et al. Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme. Oncolytic Virotherapy. 2018. doi:10.2147/ov.s179335
BibTeX
@article{Burton2018,
author = {Burton, Chase and Das, Arabinda and McDonald, Daniel and Vandergrift, William A and Patel, Sunil J and Cachia, David and Bartee, Eric},
title = {Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme},
journal = {Oncolytic Virotherapy},
year = {2018},
doi = {10.2147/ov.s179335}
}
EUVIMED